Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure
复制标题
DOI：
10.1002/ccr3.1264
复制
发表时间：
2018-01-01
影响因子：
0.7
通讯作者：
Bose, Prithviraj
中科院分区：
文献类型：
--
作者：
Alhuraiji, Ahmad;Naqvi, Kiran;Bose, Prithviraj
Philadelphia-negative (Ph-) myeloproliferative neoplasms (MPN) do rarely transform to acute lymphoblastic leukemia (ALL). While causality is difficult to establish, a few cases of ALL arising after exposure to lenalidomide for registered indications (multiple myeloma, myelodysplastic syndrome with 5q deletion) have been described in the literature.
